This issue of PET Clinics focuses on Lung Cancer, and is edited by Drs. Gang Cheng and Timothy Akhurst. Articles will include: FDG PET/CT for lung cancer staging; Lung neoplasms with low FDG avidity; FDG PET/CT evaluation of lung cancer in populations with high prevalence of granulomatous disease; Prognostic value of FDG PET/CT; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; Treatment planning for radiation therapy; Future directions of PET imaging for lung cancer; PET for RT-planning in lung cancer; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. CME Accreditation Page - p. ix 8. Preface - p. xi 9. Staging of Non–Small-Cell Lung Cancer - p. 1 10. Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity - p. 11 11. 18F-Fluoro-2-Deoxy-d-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease - p. 19 12. Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of PET in Therapeutic Response Assessment - p. 33 13. Treatment Planning for Radiation Therapy - p. 43 14. Prognostic Value of 18F-Fluorodeoxyglucose PET/Computed Tomography in Non–Small-Cell Lung Cancer - p. 59 15. Non–Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose - p. 73 16. Future Directions in PET Imaging of Lung Cancer - p. 83 17. Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET Imaging - p. 89 18. Practical Considerations for Clinical PET/MR Imaging - p. 97 19. Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer - p. 113
This issue of PET Clinics focuses on Lung Cancer, and is edited by Drs. Gang Cheng and Timothy Akhurst. Articles will include: FDG PET/CT for lung cancer staging; Lung neoplasms with low FDG avidity; FDG PET/CT evaluation of lung cancer in populations with high prevalence of granulomatous disease; Prognostic value of FDG PET/CT; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; Treatment planning for radiation therapy; Future directions of PET imaging for lung cancer; PET for RT-planning in lung cancer; Genomic characterization of lung cancer and its impact on the use and timing of PET in therapeutic response assessment; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. CME Accreditation Page - p. ix 8. Preface - p. xi 9. Staging of Non–Small-Cell Lung Cancer - p. 1 10. Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity - p. 11 11. 18F-Fluoro-2-Deoxy-d-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease - p. 19 12. Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of PET in Therapeutic Response Assessment - p. 33 13. Treatment Planning for Radiation Therapy - p. 43 14. Prognostic Value of 18F-Fluorodeoxyglucose PET/Computed Tomography in Non–Small-Cell Lung Cancer - p. 59 15. Non–Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose - p. 73 16. Future Directions in PET Imaging of Lung Cancer - p. 83 17. Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET Imaging - p. 89 18. Practical Considerations for Clinical PET/MR Imaging - p. 97 19. Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer - p. 113
